Once-a-day stimulant is safe for ADHD, can be used after 1 year

Published Date: 13 Mar 2023

New research shows that once-daily speech-stimulating medications for the treatment of ADHD in people age 6 and older are safe and effective after one year of pain treatment.

Read Full News

Latest News

New Evidence Strengthens the Case for Iatrogenic Alzheimer’s

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Experts Push Back on WHO’s ‘Misleading’ Portrayal of ECT

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Do Early Birds Have a Lower Risk for ALS?

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

Halting MOGAD Treatment Tied to Lower Relapse Risk

Stopping treatment for myelin oligodendrocyte glycoprotein antibody-associated disease is linked to fewer relapses than treatment continuation, new research shows.

FDA OKs Drug to Treat Neurologic Symptoms in Hunter Syndrome

The U.S. Food and Drug Administration has approved Denali Therapeutics' therapy to treat children ⁠with a rare genetic disorder, marking the first regulatory green light for...

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Latest News

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

Stopping treatment for myelin oligodendrocyte glycoprotein antibody-associated disease is linked to fewer relapses than treatment continuation, new research shows.

The U.S. Food and Drug Administration has approved Denali Therapeutics' therapy to treat children ⁠with a rare genetic disorder, marking the first regulatory green light for...

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

News All Time

Wildfire Smoke Tied to Higher Stroke Risk, Greater Severity

Short-term surges in air pollution from wildfire smoke have been linked to a greater incidence and severity of stroke.

Therapeutic Research in Alzheimer’s Disease: What Is New?

Long-term extension trial results with donanemab suggest a widening separation in cognitive decline through 36 months in early Alzheimer’s disease.

Adults With IDDs Face ‘Mental Health Crisis’

Adults with IDDs face disproportionately higher rates of anxiety and depression and barriers to care, prompting researchers to characterize the situation as a ‘mental health crisis.’

Reframing Dyslexia: Ancient Genes, Modern Skill

Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.

Positive Topline Results for Efgartigimod in Ocular MG

Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

Smoking + Parkinson's: Lower Disease Risk, Higher Mortality

A large nationwide study revisits the smoking-Parkinson's paradox, linking current smoking to lower disease risk but linking quitting to lower all-cause mortality.

Stem Cell Therapy Safe, Feasible in Spina Bifida

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal myelomeningocele repair.

Does Caring for Grandchildren Slow Cognitive Decline?

Grandmothers who care for grandchildren show slower cognitive decline over time than non-caregivers do.

Teen Cannabis Use Tied to Increase in Serious Mental Illness

A new study shows that teens with past-year cannabis use are twice as likely to be diagnosed with psychotic or bipolar disorders within 2 years of first use.

Fertility Treatments Linked to Higher Med Use in Offspring

Children conceived through medically assisted reproduction have higher out-of-hospital healthcare utilization including mental health medications.

Lifetime Risk Estimates for Dementia, MCI: New Data

Mild cognitive impairment before dementia is common in older adults, with women facing a higher lifetime burden and Black adults an earlier onset, new research shows.

Fibromyalgia-PTSD Link Shows Bidirectional Relationship

Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service members exposed to combat environments.

Redefining Cognitive Assessment With One Blood Test

Blood p-tau217 testing in real-world practice enhances diagnostic accuracy and neurologists' diagnostic confidence, with the greatest diagnostic shifts seen in mild cognitive impairment and dementia.

Trials Offer Mixed Results on BTK Potential for PPMS

Promising findings for fenebrutinib and disappointing results for tolebrutinib offer mixed results on the potential of BTK inhibitors for primary progressive MS.

Wrist-Worn Sleep Trackers Predict Depression Relapse

Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.

What If We’ve Been Wrong About How ADHD Drugs Work?

A new analysis of brain scans from nearly 12,000 children could change the way clinicians and researchers think about how stimulants for ADHD work.

Recommended News For You

In early dementia, SSRIs enhance cognition and major depression.

Dementia-like protein buildup found in pancreas cells before cancer develops

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

Risk of a second cancer after early breast cancer is low, say new findings

The biology of cancer as well as potential treatment options are examined by experts.

Recommended Articles For You

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia 

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide 

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights 

Chondroma: What it is and How it Affects Your Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

2.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?

5.

New research demonstrates a method for screening people at high risk for pancreatic cancer.

1.

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics

2.

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown

3.

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options 

4.

Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods

5.

Molecular & Genetic Oncology: Emerging Frontiers in 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot